Jason Zemansky

Stock Analyst

(n/a)
# 108
Out of 4,648 analysts
32
Total ratings
n/a
Success rate
n/a
Average return

Stocks Rated by Jason Zemansky

Insmed
Oct 9, 2024
Maintains: Buy
Price Target: $84$86
Current: $68.09
Upside: +26.30%
Syndax Pharmaceuticals
Aug 15, 2024
Maintains: Buy
Price Target: $30$31
Current: $18.94
Upside: +63.67%
Arcus Biosciences
Aug 9, 2024
Maintains: Neutral
Price Target: $24$23
Current: $15.56
Upside: +47.81%
Esperion Therapeutics
Jun 20, 2024
Downgrades: Underperform
Price Target: $2.9$2.5
Current: $2.00
Upside: +25.00%
Cytokinetics
May 23, 2024
Maintains: Neutral
Price Target: $70$60
Current: $51.48
Upside: +16.55%
AlloVir
Dec 26, 2023
Downgrades: Underperform
Price Target: $17$1
Current: $0.89
Upside: +12.74%
Kura Oncology
Aug 11, 2023
Initiates: Buy
Price Target: $31
Current: $17.81
Upside: +74.06%
Werewolf Therapeutics
May 12, 2023
Maintains: Buy
Price Target: $9$10
Current: $2.26
Upside: +342.48%
Allakos
Dec 13, 2021
Maintains: Buy
Price Target: $145$155
Current: $1.25
Upside: +12,300.00%